idlife cardiovascular disease (CVD) and related risk factors increase the risk of abnormal brain aging and dementia. 1, 2 VEGF (vascular endothelial growth factor), Ang2 (angiopoietin 2) and its sTie2 (soluble tyrosine kinase with immunoglobulin-like and EGF-like domains 2), and HGF (hepatocyte growth factor) are involved in regulation of vascular function. Several cardiovascular risk factors have been associated with the concentration of these growth factors, and they have in turn been related to CVD. 3, 4 However, studies relating these growth factors to magnetic resonance imaging (MRI) markers of brain aging are lacking, particularly in middle-aged adults. Furthermore, these associations have not been investigated in the context of APOE (apolipoprotein E)-ɛ4, a strong genetic risk factor for Alzheimer disease, or CRP (C-reactive protein), a marker of systemic inflammation.
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This study explored the associations of circulating VEGF, Ang2, sTie2, and HGF concentrations with MRI markers of brain aging and evaluated effect modification by APOE-ɛ4 status or CRP concentrations in middle-aged adults from the Framingham Heart Study.
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Standard immunoassays were used for measurement of serum growth factor concentrations. Brain MRI measurements included total brain, cortical and subcortical gray matter, white matter (WM), cerebrospinal fluid, and WM hyperintensity (WMH) volumes. Maps of fractional anisotropy, a measure of WM integrity, 5 were computed from diffusion tensor imaging.
Multivariable regression models were used to relate growth factor concentrations to MRI outcomes. Models were adjusted for age, age 2 , sex, time between blood draw and MRI, waist-to-hip ratio, systolic blood pressure, hypertension treatment, diabetes mellitus, current smoking, and prevalent CVD. Secondary analyses tested for interactions between our predictors and APOE (ɛ4 carriers versus noncarriers) or CRP concentrations (top quartile versus bottom 3 quartiles) in MRI outcomes. Stratified analyses were adjusted for the same set of covariates described above. We applied false discovery rate correction for multiple testing, using a P<0.05 threshold for main effects and P<0.1 threshold for interaction analyses. Further details are provided in Methods in the online-only Data Supplement.
Results
The study sample comprised participants aged 46±8 years (46% were men) with a low burden of CVD risk factors (Table 1) .
Associations between growth factor concentrations and MRI outcomes are shown in Table 2 . Higher concentrations of sTie2 were associated with higher WMH burden and lower total brain volume. Additionally, higher circulating Ang2 and HGF concentrations were associated with larger cerebrospinal fluid volumes.
Voxel-based analyses revealed significant interactions between Ang2 and APOE genotype on fractional anisotropy. APOE subgroup analyses showed significant associations between Ang2 and fractional anisotropy in APOE-ɛ4 carriers. The Table I in the online-only Data Supplement.
Discussion
Our findings suggest that circulating growth factors involved in angiogenesis and blood vessel repair are cross-sectionally associated with MRI markers of small vessel disease and neurodegeneration as early as midlife.
We observed associations of higher circulating sTie2 with both greater WMH burden and smaller total brain volumes. sTie2 plays an important role in vascular biology and is elevated in CVD. 6 Additionally, sTie2 has a high affinity for Ang1, , sex, time between blood draw and MRI, waist-to-hip ratio, systolic blood pressure, hypertension treatment, diabetes mellitus, current smoking, and prevalent cardiovascular disease. β is estimated by SD unit of logtransformed growth factor. Ang2 indicates angiopoietin 2; HGF, hepatocyte growth factor; MRI, magnetic resonance imaging; sTie2, soluble tyrosine kinase with immunoglobulin-like and EGF-like domains 2; and VEGF, vascular endothelial growth factor. *P<0.005, †P<0.05, false discovery rate corrected P values.
enabling higher concentrations of free Ang2, which promotes vascular destabilization and remodeling. 7 Disruption of the brain vascular wall may lead to leaky vessels, contributing to WM degeneration. 8 The association between higher Ang2 and larger cerebrospinal fluid volumes is consistent with the findings observed for sTie2. Furthermore, higher Ang2 is associated with decreased fractional anisotropy in APOE-ɛ4 carriers, suggesting that angiogenic factors may participate early in neurodegenerative processes, particularly in individuals at greater risk for Alzheimer disease. 9 We found that higher HGF is associated with increased cerebrospinal fluid volumes. Elevated HGF concentrations have been observed as a response element to endothelial injury and in the presence of CVD. 10, 11 It is conceivable that increased HGF constitutes a marker of disease severity, or a biological response aimed to restore vascular health.
Strengths of our investigation include the use of data from a large community-based sample with MRI measures, vascular growth factors, and potential confounders and modifiers. Limitations include the use of CRP, a nonspecific marker of inflammation, 12 and that our sample is primarily of European ancestry, limiting generalization to other races/ethnicities.
In conclusion, this study relates vascular growth factors to neurodegeneration and cerebrovascular disease as early as midlife. Future work will help determine the potential applications of these findings. Associations between higher Ang2 (angiopoietin 2) concentrations and decreased fractional anisotropy (FA) among APOE-ɛ4 carriers. T map of voxels showing a significant association between higher Ang2 and decreased FA in APOE-ɛ4 carriers. Results were adjusted for cardiovascular risk factors and corrected for multiple comparisons.
